ANIP
ANI Pharmaceuticals, Inc. (NASDAQ)
Healthcare — Drug Manufacturers - Specialty & Generic
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Price History
Fundamentals
| Market Cap | $1.88B |
| P/E Ratio (TTM) | 21.13 |
| Forward P/E | 7.73 |
| EPS (TTM) | $3.91 |
| Dividend Yield | - |
| Profit Margin | 9.98% |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | $112.71 |
| Analysts | 7 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 56.1 |
| Beta | 0.44 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | - |
| 52-Week Low | - |
| 50-Day Avg | - |
| 200-Day Avg | - |
| Avg Volume | - |
| Volume | - |
Performance Analysis
BULLISHANIP shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 01, 2026 11:46 UTC
Back to Screener Export Report